ENDOSCAPE

Residual factor IX expression in Hemophilia B patients with nonsense mutations: a determinant of inhibitory development?

Development of a RNA-based therapeutic approach for Hemophilia B caused by exon-skipping mutations

Altered mRNA processing and FVIII biosynthesis/function as determinants of phenotype variability in the frequent Arg2016Trp Haemophilia A patients.

PIATTAFORMA PER RICERCA E SVILUPPO DI PROFARMACI BIOTECNOLOGICI INNOVATIVI PER LA CURA DI MALATTIE GENETICHE RARE

RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations. PROGETTO TELETHON TRIENNALE

POST-TRANSCRIPTIONAL AND TRANSLATIONAL MECHANISMS UNDERLYING THE REGULATION OF GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS- progetto PRIN

Modulation of activators and inhibitors of coagulation by Reactive Oxygen Species (ROS) Progetto PRIN - Coordinatore Unità B